Ganli Pharmaceutical: Shareholders Minghua Innovation and Holding Plan has been implemented. During the period

Every time AI News, Gan Li Pharmaceuticals (SH 603087, closing price: 36.39 yuan) issued an announcement on the evening of September 15th that the company's shareholder Minghua Innovation and Reduction Plan was implemented. It accounts for 2%of the company's total shares.

The chairman of Gan Li Yaoye is Gan Zhongru, male, 74 years old, and his academic background is a doctoral background; the general manager is Dukai, male, 45 years old, and his academic background is a master's degree.

As of press time, Gan Li Pharmaceutical's market value was 20.4 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Gan Li Yaoye has a decrease of 747,300 shares in the north direction of the northern direction in the past 30 days, and the proportion of circulating shares decreased by 0.27%;

2. In the past 30 days, there is no opportunity to investigate Gan Li Pharmaceutical;

3. Gan Li Yaoye's last release announcement announcement was on July 26, 2022, and the second trading day rose 0.12%. Gan Li Pharmaceutical issued a total of 14 reducing categories in the past year.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Every headline (nbdtoutiao) -the dialogue Bill Gates: The ultimate goal of food assistance is no aid

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -